This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents. Top assignees: Genentech, Inc., Hoffmann-La Roche Inc., Acino Pharma Ag. Active years: 2009-2025.
Company Filing History:
2 out of 3,294 
2 out of 5,020 
1 out of 1 
Years Active: 2009-2025
Title: The Innovative Contributions of Alfred Stutz
Introduction
Alfred Stutz is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of chemistry, particularly in the synthesis of complex compounds. With a total of four patents to his name, Stutz has demonstrated a commitment to advancing scientific knowledge and applications.
Latest Patents
Stutz's latest patents include processes for the preparation of substituted 1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indoles. These processes utilize Wenker-Synthesis to facilitate the synthesis of GDC-9545. Additionally, he has developed processes for the synthesis of substituted indole intermediates, which are crucial for the total synthesis of SERD compounds used in cancer treatment.
Career Highlights
Throughout his career, Stutz has worked with prominent companies such as Genentech, Inc. and Hoffmann-La Roche Inc. His work in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Stutz has collaborated with esteemed colleagues, including Georg Wuitschik and Remy Angelaud. These partnerships have further enriched his research and innovation efforts.
Conclusion
Alfred Stutz's contributions to the field of chemistry and his innovative patents highlight his role as a significant inventor. His work continues to impact the development of important therapeutic compounds.